This document is an excerpt from the EUR-Lex website
Document 62020TN0715
Case T-715/20: Action brought on 4 December 2020 — Degode v EUIPO — Leo Pharma (Skinovea)
Case T-715/20: Action brought on 4 December 2020 — Degode v EUIPO — Leo Pharma (Skinovea)
Case T-715/20: Action brought on 4 December 2020 — Degode v EUIPO — Leo Pharma (Skinovea)
OJ C 35, 1.2.2021, p. 57–58
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
1.2.2021 |
EN |
Official Journal of the European Union |
C 35/57 |
Action brought on 4 December 2020 — Degode v EUIPO — Leo Pharma (Skinovea)
(Case T-715/20)
(2021/C 35/76)
Language of the case: English
Parties
Applicant: DEGODE — Dermago Development GmbH (Petershagen, Germany) (represented by: O. Spieker, A. Schönfleisch and N. Willich, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Leo Pharma A/S (Ballerup, Denmark)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant before the General Court
Trade mark at issue: Application for European Union word mark Skinovea — Application for registration No 17 898 565
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 4 September 2020 in Case R 337/2020-5
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order the defendant to bear the costs of the proceedings. |
Plea in law
|
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |